veronate
Biologicalexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2004 (NCT00113191)
Timeline
No events for the selected filters.
Mechanism of action
- Staphylococcus aureusImmunity, passive
Staphylococcus aureus immunity, passive
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS9LKK68BOP0 ↗
Also known as
- veronate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00113191 | N/A | May 1, 2004 | Bristol-Myers Squibb, Inhibitex |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | For profit | 1 | 1 | 1 | 2004 |
| Inhibitex | For profit | 1 | 0 | 1 | 2004 |
2 organizations
Page 1 / 1